These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8773038

  • 1. Nifedipine in migraine and tension headache: a randomised double blind crossover study.
    Shukla R, Garg RK, Nag D, Ahuja RC.
    J Assoc Physicians India; 1995 Nov; 43(11):770-2. PubMed ID: 8773038
    [Abstract] [Full Text] [Related]

  • 2. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
    Haas DC, Sheehe PR.
    Headache; 2004 Nov; 44(10):1029-37. PubMed ID: 15546268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R, Ruoff G, Smith T, Barrett PS, Ames MH, Byrd S, Kori S.
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [Abstract] [Full Text] [Related]

  • 10. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
    Charles JA, Jotkowitz S, Byrd LH.
    Headache; 2006 Mar; 46(3):503-7. PubMed ID: 16618270
    [Abstract] [Full Text] [Related]

  • 11. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D, Ambrosini A, Sándor P, Jacquy J, Laloux P, Schoenen J.
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Open-label trial of cinnarizine in migraine prophylaxis.
    Togha M, Ashrafian H, Tajik P.
    Headache; 2006 Mar; 46(3):498-502. PubMed ID: 16618269
    [Abstract] [Full Text] [Related]

  • 17. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.
    Vo AH, Satori R, Jabbari B, Green J, Killgore WD, Labutta R, Campbell WW.
    Aviat Space Environ Med; 2007 May; 78(5 Suppl):B113-8. PubMed ID: 17547312
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.